Eli Lilly & Co. (LLY) Misses Q4 EPS by 1c, Revenue Beats, FY19 EPS Guidance Misses

Eli Lilly & Co. (NYSE: LLY) reported Q4 EPS of $1.33, $0.01 worse than the analyst estimate of $1.34. Revenue for the quarter came in at $6.44 billion versus the consensus estimate of $6.28 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2019 EPS of $5.55-$5.65, versus the consensus of $5.77.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.

You May Also Be Interested In

• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
• H.B. Fuller (FUL) Tops Q3 EPS by 5c, Misses on Revenue; Offers FY26 EPS Guidance
• Darden Restaurants (DRI) Reports In-Line Q1 EPS, Misses on Revenue; Offers FY27 EPS Guidance